Michael A Postow
Joint 2016 COSA and ANZBCTG Annual Scientific Meeting
Days
Monday, 14th November
Tuesday, 15th November
Wednesday, 16th November
Thursday, 17th November
Tracks
Clinical
Supportive Care
Conference Theme Stream: Breast cancer
Search
Speakers
Michael A Postow
Abstracts this author is presenting:
Two-year overall survival (OS) rates from a randomized phase 2 trial evaluating the combination of nivolumab (NIVO) and ipilimumab (IPI) versus IPI in patients with advanced melanoma (MEL)
—
Poster Session 2